These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 1277162
1. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species. Ito N. Cancer Res; 1976 Jul; 36(7 PT 2):2528-31. PubMed ID: 1277162 [No Abstract] [Full Text] [Related]
2. The pathogenesis of experimental bladder cancer. Bryan GT. Cancer Res; 1977 Aug; 37(8 Pt 2):2813-6. PubMed ID: 326392 [Abstract] [Full Text] [Related]
3. [Animal models of bladder cancer]. Fukushima S. Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366 [Abstract] [Full Text] [Related]
4. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine. Becci PJ, Thompson HJ, Grubbs CJ, Moon RC. J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573 [No Abstract] [Full Text] [Related]
5. Early surface changes of the urinary bladder epithelium of different animal species induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine. Shirai T, Murasaki G, Tatematsu M, Tsuda H, Fukushima S. Gan; 1977 Apr; 68(2):203-12. PubMed ID: 892294 [No Abstract] [Full Text] [Related]
6. E-cadherin expression during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl) nitrosamine in rats. Oliveira PA, Colaço A, De la Cruz LF, Lopes P, Lopes C. J Exp Clin Cancer Res; 2006 Sep; 25(3):425-32. PubMed ID: 17167984 [Abstract] [Full Text] [Related]
7. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine. Suzuki E, Mochizuki M, Okada M. Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694 [Abstract] [Full Text] [Related]
8. Species variations in the metabolism of N-butyl-N-(4-hydroxybutyl) nitrosamine and related compounds in relation to urinary bladder carcinogenesis. Suzuki E, Anjo T, Aoki J, Okada M. Gan; 1983 Feb; 74(1):60-8. PubMed ID: 6840438 [Abstract] [Full Text] [Related]
9. Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds. Hirose M, Fukushima S, Hananouchi M, Shirai T, Ogiso T. Gan; 1976 Apr; 67(2):175-89. PubMed ID: 964550 [Abstract] [Full Text] [Related]
10. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine. Tsuda H, Miyata Y, Murasaki G, Kinoshita H, Fukushima S. Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292 [No Abstract] [Full Text] [Related]
11. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Kitahori Y, Konishi N, Shimoyama T, Hiasa Y. Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279 [Abstract] [Full Text] [Related]
12. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol. Szende B, Jeney A, Institoris L. Acta Morphol Hung; 1992 Sep; 40(1-4):187-93. PubMed ID: 1365762 [Abstract] [Full Text] [Related]
13. Emergence of an epidermis-associated cell surface antigen in epithelial cells of the rat urinary bladder in carcinogenesis. Masuko T, Hashimoto Y. J Natl Cancer Inst; 1981 Aug; 67(2):431-6. PubMed ID: 6943379 [Abstract] [Full Text] [Related]
14. Comparative carcinogenicity of N-butyl-N-(3-carboxypropyl)-nitrosamine and N-butyl-N-(4-hydroxybutyl)nitrosamine for the urinary bladder of (C57BL/6 X DBA/2)F1 mice. Irving CC, Murphy WM, Daniel DS. J Natl Cancer Inst; 1984 Sep; 73(3):753-6. PubMed ID: 6590920 [Abstract] [Full Text] [Related]
15. Evaluation of DNA content in preneoplastic changes of mouse urinary bladder induced by N-butyl-N-(4-hydroxybutyl) nitrosamine. Oliveira PA, Palmeira C, Lourenço LM, Lopes CA. J Exp Clin Cancer Res; 2005 Dec; 24(4):609-16. PubMed ID: 16471324 [Abstract] [Full Text] [Related]
16. Promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in rats. Fukushima S, Kurata Y, Tamano S, Inoue K, Ito N. Jpn J Cancer Res; 1985 Sep; 76(9):823-7. PubMed ID: 3932280 [Abstract] [Full Text] [Related]
17. Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats. Fukushima S, Murasaki G, Hirose M, Nakanishi K, Hasegawa R, Ito N. Acta Pathol Jpn; 1982 Mar; 32(2):243-50. PubMed ID: 7090816 [Abstract] [Full Text] [Related]
18. Possible mechanistic roles of anatomical and functional vascular changes in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine. Tatematsu M, Lurie AG, Rippey RM, Conran PB, Arai M, Fukushima S, Ito N. Cancer Res; 1984 Jan; 44(1):278-84. PubMed ID: 6690039 [Abstract] [Full Text] [Related]
19. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine. Ohtani M, Kakizoe T, Nishio Y, Sato S, Sugimura T, Fukushima S, Niijima T. Cancer Res; 1986 Apr; 46(4 Pt 2):2001-4. PubMed ID: 3948177 [Abstract] [Full Text] [Related]
20. N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder cancer in C57BL/6 X DBA/2 F1 mice as a useful model for study of chemoprevention of cancer with retinoids. Becci PJ, Thompson HJ, Strum JM, Brown CC, Sporn MB, Moon RC. Cancer Res; 1981 Mar; 41(3):927-32. PubMed ID: 7459879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]